Northbrook, United States, July 16,2019 - The global fill-finish manufacturing market is estimated to account for USD 2.96 Billion in 2017 and projected to reach USD 4.47 Billion by 2022, at a CAGR of 8.6%.
Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.
Product launches remain at the center of the strategic growth initiatives adopted by a majority of key players in the global fill-finish manufacturing market. Companies such as Schott (Germany), Stevanato (Italy), Gerresheimer (Germany), Robert Bosch (Germany), and Becton, Dickinson and Company (US) have been focusing on product launches to enhance their market presence. Players also focused on increasing their presence in high-growth markets through inorganic growth strategies, such as partnerships, collaborations, agreements, expansions, and acquisitions.
Geographically, the fill-finish manufacturing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, Europe is expected to account for the largest share of the global market.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609
The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and the increasing focus of major players on increasing their presence in Europe. The APAC region is projected to grow at the highest CAGR during the forecast period. The growth of the global market in this region is driven by the overall growth in the biopharmaceutical industry.
Isolators and RABS are equipped with advanced features and functionalities and are therefore priced at a premium, as compared to standalone systems. This severely restricts their accessibility, especially for small companies. Owing to this, the adoption of isolators and RABS is very low as compared to standalone systems in underdeveloped or developing countries, including China and India. Furthermore, research institutes find it difficult to afford such instruments, as they have restricted budgets for the purchase of such instruments. The use of standalone systems still prevails among these end users.
Europe is expected to dominate the fill-finish manufacturing market in 2017
In 2017, Europe is expected to account for the largest share of the global fill-finish manufacturing market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and increasing focus of major players on enhancing their presence in Europe.
The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the fill-finish manufacturing market in this region is fueled by the overall growth in the biopharmaceutical industry.
The key players operating in this market include Becton, Dickinson and Company (US), West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US), Gerresheimer AG (Gerresheimer) (Germany), Robert Bosch GmbH (Robert Bosch) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US).
Read More@
https://www.marketsandmarkets.com/PressReleases/fill-finish-manufacturing.asp
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
